Clinical Trial Update: Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update indicates that the study evaluating exenatide's effects on postprandial hyperlipidemia and inflammation in adults with type 2 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance
• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Carl T. Hayden VA Medical Center | Conditions: Type 2 Diabetes Mellitus, Impaired Glucose Tolerance | Phase 4 | Status: COMPLETED